Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, leukemia, neoplasm	Not yet recruiting	Phase 1	2025-08-13		NCT07120607

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Anhui Provincial Hospital	101

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials